Your browser is no longer supported. Please, upgrade your browser.
Settings
AMGN Amgen Inc. daily Stock Chart
AMGN [NASD]
Amgen Inc.
IndexS&P 500 P/E17.31 EPS (ttm)13.03 Insider Own0.21% Shs Outstand599.00M Perf Week2.66%
Market Cap135.08B Forward P/E14.29 EPS next Y15.78 Insider Trans-2.08% Shs Float590.87M Perf Month10.10%
Income8.07B PEG2.19 EPS next Q3.27 Inst Own80.20% Short Float1.53% Perf Quarter10.86%
Sales23.40B P/S5.77 EPS this Y14.80% Inst Trans0.34% Short Ratio3.65 Perf Half Y31.03%
Book/sh18.24 P/B12.36 EPS next Y9.36% ROA12.90% Target Price222.27 Perf Year15.70%
Cash/sh34.81 P/C6.48 EPS next 5Y7.92% ROE71.60% 52W Range166.30 - 225.26 Perf YTD15.84%
Dividend5.80 P/FCF23.76 EPS past 5Y13.70% ROI19.80% 52W High0.11% Beta1.10
Dividend %2.57% Quick Ratio2.60 Sales past 5Y4.90% Gross Margin82.10% 52W Low35.60% ATR3.87
Employees21500 Current Ratio2.90 Sales Q/Q-2.80% Oper. Margin42.80% RSI (14)75.75 Volatility1.71% 1.91%
OptionableYes Debt/Eq2.73 EPS Q/Q14.10% Profit Margin34.50% Rel Volume1.42 Prev Close224.50
ShortableYes LT Debt/Eq2.54 EarningsOct 29 AMC Payout43.30% Avg Volume2.48M Price225.51
Recom2.20 SMA204.97% SMA5010.33% SMA20018.70% Volume3,521,100 Change0.45%
Nov-12-19Initiated SunTrust Buy $256
Nov-05-19Upgrade Cantor Fitzgerald Neutral → Overweight $230 → $255
Oct-17-19Resumed BofA/Merrill Neutral $215
Aug-19-19Downgrade Mizuho Buy → Neutral $208 → $212
May-23-19Upgrade Citigroup Neutral → Buy
May-21-19Initiated Credit Suisse Outperform $208
Jan-28-19Downgrade Evercore ISI Outperform → In-line
Oct-01-18Initiated Cantor Fitzgerald Neutral $223
Apr-05-18Reiterated Barclays Equal Weight $190 → $180
Feb-12-18Reiterated Mizuho Buy $192 → $200
Jan-23-18Upgrade Argus Hold → Buy
Nov-01-17Downgrade Argus Buy → Hold
Oct-26-17Reiterated RBC Capital Mkts Sector Perform $192 → $188
Sep-28-17Reiterated Mizuho Buy $183 → $198
Sep-15-17Initiated RBC Capital Mkts Sector Perform $192
Jul-11-17Resumed Jefferies Buy
Jun-23-17Initiated Deutsche Bank Hold $172
Apr-05-17Downgrade Jefferies Buy → Hold
Mar-09-17Initiated UBS Neutral $185
Feb-01-17Upgrade BofA/Merrill Neutral → Buy
Nov-20-19 04:36PM  Bristol-Myers Squibb completes $74 billion acquisition of Celgene MarketWatch
12:08PM  Yield Curve Inversion: The Complete Picture GuruFocus.com
Nov-19-19 11:02AM  A $5 Billion Cholesterol Bet May Be an Overreach Bloomberg
10:32AM  Merck's Heart Failure Candidate Meets Goal in Phase III Study Zacks
10:23AM  Pfizer Gets FDA Approval for Biosimilar of AbbVie's Humira Zacks
10:14AM  4 Big Biotech Stocks Worth Considering Post Q3 Earnings Zacks
Nov-18-19 09:18AM  Bristol-Myers Gets FTC Clearance for Celgene Acquisition Zacks
09:00AM  New Results From COSMIC-HF Presented At AHA 2019 Show Treatment Of Heart Failure Patients With Omecamtiv Mecarbil Was Associated With Neutral Or Improved Measures Of Diastolic Function PR Newswire
09:00AM  New Results From COSMIC-HF Presented at AHA 2019 Show Treatment of Heart Failure Patients With Omecamtiv Mecarbil Was Associated With Neutral or Improved Measures of Diastolic Function GlobeNewswire
Nov-17-19 03:40PM  AbbVie's Humira on Pace to Become Biggest Seller by 2024 GuruFocus.com
Nov-16-19 09:00AM  Amgen Announces New FOURIER Analysis Showing Benefit Of Repatha® (evolocumab) In High-Risk Patients Who Have Experienced A Recent Heart Attack PR Newswire
Nov-15-19 05:43PM  FTC makes Celgene's Otezla divestiture official condition for Bristol-Myers acquisition MarketWatch
09:10AM  Amarin (AMRN) Gets FDA Panel Nod for Vascepa Label Expansion Zacks
09:00AM  Amgen And The Duke Clinical Research Institute Announce Initiation Of First Large-Scale Registry To Evaluate Real-World Lipid Management And The Effectiveness Of PCSK9 Inhibitors PR Newswire
Nov-14-19 09:58AM  Alexion (ALXN) Up 10 % YTD on Soliris & Ultomiris Strength Zacks
Nov-12-19 11:37AM  Buy Big Biotech But Not Gilead, Analyst Says Barrons.com
08:26AM  Should First Trust Capital Strength ETF (FTCS) Be on Your Investing Radar? Zacks
Nov-11-19 12:51PM  Drugmaker Amgen cuts a quarter of its Kendall Square research staff American City Business Journals
09:00AM  Amgen Highlights Data To Be Presented At AHA 2019 Across Cardiovascular Portfolio PR Newswire
07:04AM  Amgen at 52-Week Highs Bumps Against Resistance, Remains a Long-Term Hold TheStreet.com
Nov-08-19 08:24AM  Biotech Funds Are Beating the Market, but Investors Are Still Bailing Out Barrons.com
Nov-07-19 05:01PM  Amgen To Present At The 28th Annual Credit Suisse Healthcare Conference PR Newswire
Nov-06-19 11:10AM  Radius (RDUS) Q3 Earnings Beat Estimates on Tymlos Strength Zacks
09:33AM  Ligand's (LGND) Q3 Earnings Miss Estimates, EPS View Down Zacks
Nov-05-19 03:57PM  Top Analyst Reports for Verizon, McDonald's & TOTAL Zacks
01:56PM  The Biggest Biotech Just Touched A Record High Is Amgen Stock A Buy? Investor's Business Daily
11:02AM  Allergan (AGN) Meets Q3 Earnings Estimates, Ups '19 Sales View Zacks
10:00AM  Looking For Growth? Take A Look At These Biotechnology Stocks Investor's Business Daily
04:59AM  Novartis gets U.S. nod for long-delayed Amgen copycat Reuters
Nov-04-19 05:05PM  Biotech ETFs in Focus on Impressive Q3 Earnings Results Zacks
01:00PM  Value Biotech ETFs & Stocks to Buy Now Zacks
11:38AM  What's in the Cards for Teva (TEVA) This Earnings Season? Zacks
11:23AM  Drug/Biotech Stocks Nov 5 Earnings Roster: AGN, REGN & More Zacks
11:20AM  Eaton Vance Worldwide Health Sciences Fund Buys 2 Stocks GuruFocus.com
01:00AM  Rounding Up Big Pharma Earnings Morningstar
Nov-01-19 03:18PM  Biotech ETFs Strengthen as Amgen Invests in Chinas BeiGene ETF Trends
02:47PM  AbbVie (ABBV) Beats on Q3 Earnings & Sales, Tweaks EPS View Zacks
02:40PM  Amgen Inc. -- Moody's: Amgen's BeiGene collaboration will expand geographic reach but reduce cash Moody's
07:38AM  The Daily Biotech Pulse: Amgen Takes 20.5% Stake In BeiGene, Paratek's Mixed Clinical Readout, CareDx Slips On Guidance Benzinga
04:53AM  Amgen to Take $2.7 Billion Stake in BeiGene for China Growth Bloomberg
04:20AM  Drug Companies Are a Political Football, Trading Amgen: Market Recon TheStreet.com
03:01AM  Jobs Report, Exxon, Pinterest, Amgen, U.S. Steel - 5 Things You Must Know Friday TheStreet.com
Oct-31-19 05:28PM  Amgen Is Taking A $2.7 Billion Stake In A Chinese Biotech Here's Why Investor's Business Daily
04:19PM  Amgen acquires one-fifth of Chinese biotech BeiGene MarketWatch
04:00PM  BeiGene Announces Global Strategic Oncology Collaboration with Amgen GlobeNewswire
04:00PM  Amgen Enters Into Strategic Collaboration With BeiGene To Expand Oncology Presence In China PR Newswire
03:49PM  [video]Amgen Takes $2.7 Billion Stake in BeiGene to Expand Access to China TheStreet.com
01:12PM  Celgene (CELG) Q3 Earnings Beat, Otezla, Revlimid Sales Rise Zacks
11:37AM  Bristol-Myers' (BMY) Q3 Earnings & Revenues Beat Estimates Zacks
11:36AM  The Zacks Analyst Blog Highlights: Alexion, Amgen, Gilead and AMAG Zacks
09:12AM  We Prescribe Amgen to Treat Your Portfolio TheStreet.com
Oct-30-19 06:41PM  Edited Transcript of AMGN earnings conference call or presentation 29-Oct-19 9:00pm GMT Thomson Reuters StreetEvents
06:00PM  The Discovery Of Amgen's Novel Investigational KRAS(G12C) Inhibitor AMG 510 Published In Nature PR Newswire
11:35AM  Amgen Reports Lower 3rd-Quarter Sales GuruFocus.com
11:12AM  Amgen (AMGN) Beats on Q3 Earnings, Ends Neuroscience R&D Zacks
10:56AM  Biotech Stock Roundup: Q3 Earnings Beat at ALXN & AMGN, Pipeline Updates & More Zacks
07:01AM  The Daily Biotech Pulse: Novartis Program Placed On Partial Clinical Hold, Adcom Snub For Amag, Amgen Earnings Benzinga
06:33AM  Does Amgen Inc.'s (NASDAQ:AMGN) CEO Salary Compare Well With Others? Simply Wall St.
06:15AM  Bristol-Myers Squibb Reports Earnings Tomorrow. Heres What to Expect. Barrons.com
Oct-29-19 11:48PM  Organizers pulling plug on Amgen Tour of California for 2020 American City Business Journals
05:28PM  Amgen Stock Dips As Knockoff Drugs Chip Away At Several Blockbusters Investor's Business Daily
05:15PM  Amgen (AMGN) Q3 Earnings and Revenues Top Estimates Zacks
05:12PM  UPDATE 2-Amgen posts higher biosimilar sales, ends neuroscience program Reuters
04:14PM  Amgen stock rises after company's profit, revenue beat MarketWatch
04:12PM  Amgen posts higher biosimilar sales, ends neuroscience program Reuters
04:12PM  Amgen third-quarter revenue falls 3%, biosimilar sales rise Reuters
04:01PM  Amgen Reports Third Quarter 2019 Financial Results PR Newswire
12:04PM  Amgen Earnings, Revenue Beat in Q3 Investing.com
10:40AM  Exelixis (EXEL) to Report Q3 Earnings: What's in the Cards? Zacks
10:25AM  Is a Beat in Store for Amarin (AMRN) This Earnings Season? Zacks
10:17AM  Amgen Rises 3% Investing.com
10:03AM  Pfizer (PFE) Rises on Q3 Earnings & Sales Beat, Ups EPS View Zacks
09:30AM  Has Amgen (AMGN) Outpaced Other Medical Stocks This Year? Zacks
09:00AM  Amgen (AMGN) Moves to Buy: Rationale Behind the Upgrade Zacks
08:46AM  Cigna (CI) to Report Q3 Earnings: What's in the Offing? Zacks
Oct-28-19 05:05PM  5 Cheap Stocks Near 52-Week Highs GuruFocus.com
04:15PM  Mirati drug shrinks tumors in some cancer patients in early-stage trial Reuters
11:59AM  Drug/Biotech Stock Q3 Earnings Due on Oct 29: MRK, PFE & More Zacks
11:22AM  Teladoc (TDOC) to Report Q3 Earnings: What's in the Cards? Zacks
10:21AM  Should You Buy Amgen (AMGN) Ahead of Earnings? Zacks
Oct-27-19 12:56PM  The Week Ahead In Biotech: Adcom Test For Agile; Pfizer, Merck Lead Earnings Benzinga
Oct-25-19 12:12PM  Will Nuplazid Aid Growth for ACADIA (ACAD) in Q3 Earnings? Zacks
12:06PM  Can CF Drugs Drive Growth for Vertex (VRTX) in Q3 Earnings? Zacks
11:25AM  Amgen (AMGN) to Report Q3 Earnings: What's in the Cards? Zacks
Oct-24-19 04:08PM  Amgen Cuts The Price Of A Key Drug Prodding A Rival Biotech To Slide Investor's Business Daily
04:00PM  Amgen Announces Webcast of 2019 Third Quarter Financial Results PR Newswire
11:24AM  Acorda (ACOR) to Post Q3 Earnings: What's in the Cards? Zacks
11:09AM  The Zacks Analyst Blog Highlights: Biogen, Vertex, Amgen, Alexion and Achillion Pharmaceuticals Zacks
11:04AM  The Zacks Analyst Blog Highlights: Microsoft, Comcast, AT&T, Amgen and GlaxoSmithKline Zacks
10:30AM  UPDATE 1-Amgen sets one lower list price for its cholesterol drug Reuters
10:25AM  Can Merck (MRK) Keep the Earnings Beat Streak Alive in Q3? Zacks
10:16AM  Pfizer (PFE) to Report Q3 Earnings: What's in the Cards? Zacks
09:20AM  Amgen slashes price tag on cholesterol medicine Repatha by 60% for 2020 Reuters
09:00AM  Amgen To Make Repatha® (evolocumab) Available Exclusively At Its Lower List Price Option In 2020 PR Newswire
Oct-23-19 04:00PM  Amgen Recommends Rejection Of 'Mini-Tender' Offer From TRC Capital Corporation PR Newswire
10:07AM  Will Strong Jakafi Sales Drive Incyte's (INCY) Q3 Earnings? Zacks
10:01AM  Lilly (LLY) Q3 Earnings Top Estimates, Sales Lag, Stock Down Zacks
09:45AM  Biotech Stock Roundup: BIIB Up on AD Data, ALXN to Buy ACHN & Other Pipeline Updates Zacks
08:48AM  5 High-Flying Corporate Giants Set to Beat on Q3 Earnings Zacks
Oct-22-19 07:22PM  David Meline, Amgen's Chief Financial Officer, To Retire PR Newswire
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It offers products for the treatment of oncology/hematology, cardiovascular, inflammation, bone health, and neuroscience. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta, a pegylated protein to treat cancer patients; Prolia to treat postmenopausal women with osteoporosis; Aranesp to treat anemia; Xgeva for skeletal-related events prevention; Sensipar/Mimpara products to treat sHPT in chronic kidney disease; and EPOGEN to treat a lower-than-normal number of red blood cells. It also markets other products in various markets, including Kyprolis, Nplate, Vectibix, Repatha, NEUPOGEN, Parsabiv, Blincyto, Aimovig, Imlygic, Corlanor, Kanjintitm, and Amgevitatm. Amgen Inc. serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors, as well as direct-to-consumer channels. The company has collaborative agreements with Novartis; UCB; Bayer HealthCare Pharmaceuticals Inc.; Syapse; and DaVita Inc., as well as strategic research partnership with the University of Washington's Institute for Protein Design. Amgen Inc. was founded in 1980 and is headquartered in Thousand Oaks, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
SUGAR RONALD DDirectorNov 06Option Exercise54.712,000109,42016,436Nov 07 06:20 PM
Williams R SandersDirectorNov 06Sale215.4542591,5665,413Nov 07 06:22 PM
SUGAR RONALD DDirectorNov 06Sale215.452,000430,90014,436Nov 07 06:20 PM
SUGAR RONALD DDirectorOct 02Option Exercise54.712,000109,42016,436Oct 03 05:06 PM
SUGAR RONALD DDirectorOct 02Sale193.582,000387,16014,436Oct 03 05:06 PM
SUGAR RONALD DDirectorSep 04Option Exercise54.712,000109,42016,336Sep 04 06:08 PM
SUGAR RONALD DDirectorSep 04Sale206.702,000413,40014,336Sep 04 06:08 PM
Patton Cynthia MSVP & CCOAug 30Option Exercise158.438,6241,366,33132,648Sep 04 06:07 PM
Patton Cynthia MSVP & CCOAug 30Sale208.0713,4262,793,51022,097Sep 04 06:07 PM
SUGAR RONALD DDirectorAug 07Option Exercise54.712,000109,42016,336Aug 08 07:09 PM
Williams R SandersDirectorAug 07Sale183.0442577,7925,838Aug 08 07:12 PM
SUGAR RONALD DDirectorAug 07Sale183.042,000366,08014,336Aug 08 07:09 PM
SUGAR RONALD DDirectorJul 03Option Exercise54.712,000109,42016,336Jul 08 04:23 PM
SUGAR RONALD DDirectorJul 03Sale187.582,000375,16014,336Jul 08 04:23 PM
SUGAR RONALD DDirectorJun 05Option Exercise54.712,000109,42016,219Jun 05 06:55 PM
SUGAR RONALD DDirectorJun 05Sale175.682,000351,36014,219Jun 05 06:55 PM
SUGAR RONALD DDirectorMay 01Option Exercise54.712,000109,42015,092May 03 05:37 PM
SUGAR RONALD DDirectorMay 01Sale175.732,000351,46013,092May 03 05:37 PM
SUGAR RONALD DDirectorApr 03Option Exercise54.712,000109,42015,092Apr 03 06:27 PM
SUGAR RONALD DDirectorApr 03Sale193.182,000386,36013,092Apr 03 06:27 PM
SUGAR RONALD DDirectorMar 06Option Exercise54.712,000109,42014,988Mar 08 07:47 PM
SUGAR RONALD DDirectorMar 06Sale188.882,000377,76012,988Mar 08 07:47 PM
SUGAR RONALD DDirectorFeb 07Option Exercise54.712,000109,42014,988Feb 11 09:27 PM
SUGAR RONALD DDirectorFeb 07Sale190.002,000380,00012,988Feb 11 09:27 PM
Jacks TylerDirectorDec 06Option Exercise82.6020,0001,652,00028,979Dec 10 08:46 PM
Jacks TylerDirectorDec 06Sale195.4120,0003,908,2328,979Dec 10 08:46 PM
Piacquad DavidSVP, Business DevelopmentNov 30Option Exercise54.696,500355,48545,128Dec 03 08:13 PM
Patton Cynthia MSVP & CCONov 29Option Exercise54.691,77797,18423,090Dec 03 08:11 PM
Patton Cynthia MSVP & CCONov 29Sale202.881,777360,52021,313Dec 03 08:11 PM